Evaluation of UCPVax Plus Nivolumab as Second Line Therapy in Advanced Non Small Cell Lung Cancer
Clinical trial NCT04263051 · COMPLETED
Trial details
- NCT number
- NCT04263051
- Sponsor
- Centre Hospitalier Universitaire de Besancon
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-09
- Primary completion
- 2023-11-22
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.